4
Changes in Ownership
Milestone Pharmaceuticals Inc. Filed Acc 0001209191-22-033336
Director bought 5,000 shares at $5.60 ($28,000)
- Director acquired 76,780 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| TRUEX PAUL F Director | 2022-05-31 | Option exercise | +8,016 | $1.12 | $8,978 | 8,016 | D |
| TRUEX PAUL F Director | 2022-05-31 | Option exercise | +45,072 | $1.54 | $69,411 | 53,088 | D |
| TRUEX PAUL F Director | 2022-05-31 | Option exercise | +22,870 | $1.54 | $35,220 | 75,958 | D |
| TRUEX PAUL F Director | 2022-05-31 | Option exercise | +822 | $2.66 | $2,187 | 76,780 | D |
| TRUEX PAUL F Director | 2022-05-31 | Purchase | +5,000 | $5.60 | $28,000 | 81,780 | D |
| Derivatives | |||||||
| TRUEX PAUL F Director | 2022-05-31 | Option exercise · Stock Option (right to buy) | −8,016 | 0 | D | ||
| TRUEX PAUL F Director | 2022-05-31 | Option exercise · Stock Option (right to buy) | −45,072 | 0 | D | ||
| TRUEX PAUL F Director | 2022-05-31 | Option exercise · Stock Option (right to buy) | −22,870 | 2,659 | D | ||
| TRUEX PAUL F Director | 2022-05-31 | Option exercise · Stock Option (right to buy) | −822 | 117 | D | ||
| Open-market purchases · 5,000 sh · avg $5.60 · $28,000 | |||||||
Loading xslF345X03/doc4.xml…